Highlights in Metastatic Breast Cancer from SABCS 2022

被引：0

作者：

Rugo, Hope S. ^{[1
,2
]}

机构：

[1] Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, Breast Oncol & Clin Trials Educ, San Francisco, CA 94143 USA

[2] Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, Med, Div Hematol & Oncol, San Francisco, CA 94143 USA

来源：

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：12 / 15

页数：4

共 13 条

[1] Bardia A, 2022, 2022 SAN ANT BREAST
[2] ClinicalTrials.gov, ClinicalTrials.gov protocol registration data element definitions for interventional and observational studies. ClinicalTrials.- gov protocol registration data element definitions for interventional and observational studies
[3] Hurvitz S, 2022, 2022 SAN ANT BREAST
[4] Johnston S, 2022, 2022 SAN ANT BREAST
[5] Krop I, 2022, 2022 SAN ANT BREAST
[6] Lu YS, 2022, 2022 SAN ANT BREAST
[7] Trastuzumab Deruxtecan in Previously Treated HER2-Low Advanced Breast Cancer
Modi, Shanu
Jacot, William
Yamashita, Toshinari
Sohn, Joohyuk
Vidal, Maria
Tokunaga, Eriko
Tsurutani, Junji
Ueno, Naoto T.
Prat, Aleix
Chae, Yee Soo
Lee, Keun Seok
Niikura, Naoki
Park, Yeon Hee
Xu, Binghe
Wang, Xiaojia
Gil-Gil, Miguel
Li, Wei
Pierga, Jean-Yves
Im, Seock-Ah
Moore, Halle C. F.
Rugo, Hope S.
Yerushalmi, Rinat
Zagouri, Flora
Gombos, Andrea
Kim, Sung-Bae
Liu, Qiang
Luo, Ting
Saura, Cristina
Schmid, Peter
Sun, Tao
Gambhire, Dhiraj
Yung, Lotus
Wang, Yibin
Singh, Jasmeet
Vitazka, Patrik
Meinhardt, Gerold
Harbeck, Nadia
Cameron, David A.
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 2022, 387 (01) : 9 - 20
[8] Oliveira M, 2022, 2022 SAN ANT BREAST
[9] Palbociclib After CDK4/6i and Endocrine Therapy (PACE), A Randomized Phase II Study of Fulvestrant, Palbociclib, and Avelumab for Endocrine Pre-treated ER+/HER2- Metastatic Breast Cancer
[10] Prat A, 2022, 2022 SAN ANT BREAST